• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

20.73 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? ↗
August 18, 2026
Wood's $498,000 purchase through a trust vehicle expands his beneficial stake to 338,103 shares as the medical robotics firm navigates losses despite $337.3 million in trailing revenue. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
PROCEPT BioRobotics (PRCT) Q2 2026 Earnings Call Transcript ↗
August 11, 2026
HYDROS revenue surged 32% amid legacy account softness and accelerated replacements. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
PROCEPT BioRobotics Q2 Earnings Call Highlights ↗
August 04, 2026
PROCEPT BioRobotics (NASDAQ:PRCT) reported second-quarter revenue growth of 19% year over year while lowering its full-year U.S. procedure outlook, citing softer activity at legacy AquaBeam accounts.... 
Via MarketBeat
Topics Artificial Intelligence Earnings
Procept BioRobotics (NASDAQ:PRCT) Q2 In Line, But Unchanged Guidance Sinks Shares ↗
August 04, 2026
Via Chartmill
PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) Q1 Earnings Beat Drives 13% Surge Despite Net Loss ↗
April 29, 2026
Via Chartmill
Topics Earnings
PROCEPT BioRobotics Corp (NASDAQ:PRCT) Plummets 27% After Q4 Earnings Miss and Slashed 2026 Guidance ↗
February 25, 2026
Via Chartmill
Topics Earnings
News headline image
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch ↗
May 23, 2026
Biotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations. 
Via The Motley Fool
News headline image
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗
May 23, 2026
GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
5 Robotics Stocks to Watch as Physical AI Builds Momentum ↗
May 18, 2026
Via MarketBeat
Topics Artificial Intelligence
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
August 06, 2025
 
Via Benzinga
News headline image
Procept (PRCT) Q1 2026 Earnings Transcript ↗
April 30, 2026
Procept (PRCT) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
What's going on in today's after hours session ↗
April 29, 2026
Via Chartmill
News headline image
Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock ↗
April 24, 2026
This surgical robotics firm develops minimally invasive systems for urologic procedures, targeting hospitals and specialty clinics. 
Via The Motley Fool
News headline image
PROCEPT BioRobotics (PRCT) Earnings Transcript ↗
April 14, 2026
PROCEPT BioRobotics (PRCT) Earnings Transcript 
Via The Motley Fool
Topics World Trade
There are notable gap-ups and gap-downs in today's session. ↗
February 26, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
February 26, 2026
Via Chartmill
News headline image
PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why ↗
February 26, 2026
PROCEPT BioRobotics (NASDAQ: PRCT) shares down on Q4 2025 results and updated revenue guidance. Q1 sales expected at $79-82 million. 
Via Benzinga
News headline image
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 ↗
February 26, 2026
Bank of America reduced its rating on PROCEPT BioRobotics to ‘Underperform’ from ‘Neutral’. 
Via Stocktwits
Topics Artificial Intelligence
Top movers in Wednesday's after hours session ↗
February 25, 2026
Via Chartmill
News headline image
After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Million ↗
February 01, 2026
This healthcare technology firm develops robotic surgical systems for minimally invasive urology procedures targeting BPH treatment. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Underrated Robotics Stocks Poised for Huge Gains ↗
December 15, 2025
Via MarketBeat
News headline image
2 Robotics Stocks Riding the Sensor and Medical Boom ↗
October 29, 2025
The robotics infrastructure layer is delivering explosive returns. 
Via The Motley Fool
News headline image
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? ↗
October 24, 2025
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? 
Via The Motley Fool
News headline image
Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock ↗
October 15, 2025
 
Via Benzinga
News headline image
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts ↗
September 02, 2025
 
Via Benzinga
News headline image
Procept (PRCT) Q2 Revenue Jumps 48% ↗
August 06, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
PROCEPT BioRobotics (PRCT) Earnings Transcript ↗
August 06, 2025
Via The Motley Fool
Topics World Trade
News headline image
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline ↗
August 06, 2025
PROCEPT BioRobotics posted strong Q2 2025 revenue growth of 48% YoY but missed profitability estimates, triggering an 8% stock drop. The surgical robotics firm raised full-year guidance but faces... 
Via Chartmill
News headline image
Uncovering Potential: PROCEPT BioRobotics's Earnings Preview ↗
August 05, 2025
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap